Healthcare | May 29, 2025
USV’s ‘United for BP Control’ Mission takes aim at India’s blood pressure epidemic
The initiative was announced at World Hypertension Congress, Chennai
The initiative was announced at World Hypertension Congress, Chennai
Enpatoran is a potential first-in-class oral therapy for CLE and SLE that is thought to selectively block the activation of Toll-like receptors (TLR)7 and TLR8
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The stethoscope features high acoustic sensitivity and active noise cancellation, minimizing ambient interference to improve auscultation clarity, particularly in noisy hospital settings
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Subscribe To Our Newsletter & Stay Updated
